You just read:

Study Published in Science Translational Medicine Reports Favorable Safety and Extended Survival for Brain Cancer Patients Treated with Tocagen's Cancer-Selective Viral Gene Therapy

News provided by

Tocagen Inc.

Jun 01, 2016, 14:00 ET